TrialArchives of disease in childhood2024

High-dose intravenous immunoglobulin versus albumin 4% in paediatric toxic shock syndrome: a randomised controlled feasibility study.

Aurélie Portefaix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.